a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system.
Industry Biotechnology
A.I.dvisor indicates that over the last year, ARTL has been loosely correlated with PALI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTL jumps, then PALI could also see price increases.
Ticker / NAME | Correlation To ARTL | 1D Price Change % | ||
---|---|---|---|---|
ARTL | 100% | -1.54% | ||
PALI - ARTL | 34% Loosely correlated | +4.82% | ||
TRVN - ARTL | 27% Poorly correlated | +4.06% | ||
LSTA - ARTL | 26% Poorly correlated | -1.76% | ||
PHIO - ARTL | 26% Poorly correlated | -2.94% | ||
ONCY - ARTL | 25% Poorly correlated | -0.92% | ||
More |